Pain and Inflammation Research
Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.
Pain and Inflammation Research Products Areas
Products for Pain and Inflammation Research - Page 86
- Cat.No. Product Name Information/Activity
-
BCC6156
MNI 137
946619-21-2
-
BCC7866
Xanthurenic acid
Xanthurenic acid is a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus.
-
BCC1487
Clozapine N-oxide (CNO)
Activator of muscarinic DREAADs,Clozapine N-oxide is a pharmacologically inert metabolite of Clozapine, which is a potent <b>5-HT1C</b> receptor antagonist.
-
BCC5702
ACPT-I
194918-76-8
-
BCC7344
AMN 082 dihydrochloride
The first selective mGlu<sub>7</sub> agonist
-
BCC6550
L-AP4
L-APB is a potent and specific agonist for the group III mGluRs, with EC50s of 0.13, 0.29, 1.0, 249 μM for mGlu4, mGlu8, mGlu6 and mGlu7 receptors, respectively.
-
BCC7865
Cinnabarinic acid
606-59-7
-
BCC7045
(RS)-3,4-DCPG
176796-64-8
-
BCC7012
(S)-3,4-DCPG
201730-11-2
-
BCC7652
NPEC-caged-(S)-3,4-DCPG
1257323-85-5


